<DOC>
	<DOCNO>NCT00300131</DOCNO>
	<brief_summary>Prospective , open-labeled First Man Clinical Investigation enrol patient visually estimate nominal vessel diameter 3.0 mm receive single 3.0 x 12 mm 3.0 x 18 mm BVS EECSS contain 98 microgramme per cm² surface area .</brief_summary>
	<brief_title>ABSORB Clinical Investigation , Cohort A ( ABSORB A ) Everolimus Eluting Coronary Stent System Clinical Investigation</brief_title>
	<detailed_description>- Prospective , open-labeled Clinical Investigation enrol patient visually estimate nominal vessel diameter 3.0 mm lesion length ≥ 8 mm receive single 3.0 x 12 mm BVS Everolimus Eluting CSS contain 98 microgramme per cm² surface area . Lesion length expand to≥ 14 mm length visual estimation 3.0 x 18 mm stent available . - Angiographic , Intravascular Ultrasound ( IVUS ) , Intravascular Ultrasound- virtual histology ( IVUS-VH ) Palpography follow-up carry patient 180 day 2 year follow index procedure - Optical Coherence Tomography ( OCT ) follow-up 180 day 2 year carry subset 10 patient Cohorts A B respectively enrol pre-determined clinical site ( ) - Multi-slice Spiral Computed Tomography ( MSCT ) optional procedure may carry 18 month post procedure 4 5 year follow . - Additionally , coronary vasomotion test may do 2 year post procedure Single patient Cohort 30 . Pipeline product . Currently development Abbott Vascular . Not available sale .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Target lesion must locate native epicardial vessel visually estimate nominal vessel diameter 3.0 mm Target lesion must measure less/equal 8 mm length visual estimation 3.0 x 12 mm , expand less/equal 14 mm length visual estimation 3.0 x 18 mm stent available The target lesion ( ) must major artery branch visually estimate stenosis &gt; 50 % &lt; 100 % TIMI flow greater/equal 1 NonClinical Investigation , percutaneous intervention lesion nontarget vessel allow do more/equal 90 day prior plan do 6 month index procedure NonClinical Investigation , percutaneous intervention lesion target vessel allow do &gt; 6 month prior plan do 6 month index procedure Located within arterial saphenous vein graft distal diseased ( defined vessel irregularity per angiogram &gt; 20 % stenosed lesion visual estimation ) arterial saphenous vein graft Lesion involve bifurcation greater/equal 2 mm diameter ostial lesion &gt; 40 % stenosed visual estimation side branch require predilatation Total occlusion ( TIMI flow 0 ) , prior wire pass The target vessel contain visible thrombus Another clinically significant lesion locate epicardial vessel ( include side branch ) target lesion Patient receive brachytherapy epicardial vessel ( include side branch )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Bioabsorbable</keyword>
	<keyword>Coronary Stent</keyword>
	<keyword>Everolimus</keyword>
	<keyword>drug elute stent</keyword>
	<keyword>stent</keyword>
	<keyword>angioplasty</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>total coronary occlusion</keyword>
	<keyword>coronary artery restenosis</keyword>
	<keyword>stent thrombosis</keyword>
	<keyword>vascular disease</keyword>
	<keyword>myocardial ischemia</keyword>
	<keyword>coronary artery stenosis</keyword>
</DOC>